Treatment

Test IMP (EDG-5506) without active substance clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Effect of EDG-5506 on Biomarker Response to Exercise in Adults with Becker Muscular Dystrophy, McArdle Disease, or Limb-Girdle Muscular Dystrophy
This study is testing a new medicine, EDG-5506, for people with Becker muscular dystrophy, McArdle disease, or limb-girdle muscular dystrophy. We want to see if it helps reduce muscle damage and if it's safe. It's compared to a dummy medicine.
For: McArdle Disease · Limb-Girdle Muscular Dystrophy · Becker Muscular Dystrophy
Denmark